期刊文献+

血管生成素对稳定性心绞痛择期经皮冠状动脉介入治疗后心肌梗死发生的预测价值 被引量:4

下载PDF
导出
摘要 目的探讨稳定性心绞痛患者择期经皮冠状动脉介入治疗(PCI)后心肌梗死发生的危险因素分析及血管生成素2/血管生成素1(Angpt2/Angpt1)比值的预测价值。方法选取2016年1月至2019年1月间在海南西部中心医院接受择期PCI治疗的心绞痛患者138例作为心绞痛组,同期在本院进行体检的健康志愿者100例作为对照组,对比其血清Angpt2、Angpt1水平及Angpt2/Angpt1比值的差异。根据PCI后90 d是否发生心肌梗死将稳定性心绞痛患者分为心肌梗死组18例、非心肌梗死组120例,对比其临床资料差异。采用Logistic回归分析稳定性心绞痛患者择期PCI后心肌梗死发生的危险因素,采用受试者工作特征(ROC)曲线分析Angpt2/Angpt1比值对择期PCI后心肌梗死发生的预测价值。结果心绞痛组患者的血清Angpt2水平及Angpt2/Angpt1比值高于对照组,Angpt1水平低于对照组(t=10.693、20.582、10.505,P<0.05)。心肌梗死组、非心肌梗死组患者的吸烟、合并糖尿病、病变血管支数、超敏C反应蛋白(hs-CRP)、总胆固醇(TC)分布差异有统计学意义(t/χ^(2)=5.560、8.776、13.642、8.145、3.002,P<0.05)。Logistic回归分析发现,吸烟、合并糖尿病及hs-CRP、TC、Angpt2/Angpt1水平较高是稳定性心绞痛患者择期PCI后心肌梗死发生的独立危险因素(P<0.05)。ROC曲线结果显示,Angpt2/Angpt1比值预测稳定性心绞痛患者择期PCI后心肌梗死发生的最佳截断值为3.830,AUC为0.717,95%CI=0.608~0.826。对应的敏感度、特异度分别为65.0%、66.67%。结论稳定性心绞痛患者择期PCI后心肌梗死发生的危险因素包括吸烟、合并糖尿病及hs-CRP、TC、Angpt2/Angpt1水平较高,尤其Angpt2/Angpt1比值在早期预测后续心肌梗死发生方面具有一定作用。
出处 《心脑血管病防治》 2021年第4期408-410,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献4

二级参考文献83

  • 1边素艳,刘宏斌,杨庭树.提高急性心肌梗死大鼠模型存活率的实验研究[J].中国康复医学杂志,2005,20(3):180-182. 被引量:13
  • 2Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 3Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 4Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 5Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 6O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 7Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 8Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 9Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 10Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.

共引文献2114

同被引文献57

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部